$2.7亿
申报组合市值
| # | 证券 | 股数 | 股数环比 | 市值 | 占其组合 |
|---|---|---|---|---|---|
| 1 | DCTH Delcath Sys Inc | 3.3M | +0.0% | $4155万 | 15.4% |
| 2 | FENC Fennec Pharmaceuticals Inc | 3.2M | +9.6% | $3427万 | 12.7% |
| 3 | XERS Xeris Biopharma Holdings Inc | 2.9M | −10.0% | $2304万 | 8.6% |
| 4 | SVRA Savara Inc | 3.2M | −0.8% | $1958万 | 7.3% |
| 5 | VSTM Verastem Inc | 4.0M | +86.4% | $1523万 | 5.7% |
| 6 | XFOR X4 Pharmaceuticals Inc | 3.2M | +0.0% | $1501万 | 5.6% |
| 7 | EYPT Eyepoint Inc | 988,230 | −4.7% | $1413万 | 5.2% |
| 8 | HELP Cybin Inc | 2.0M | +27.7% | $1293万 | 4.8% |
| 9 | VOR Vor Biopharma Inc | 648,600 | −7.3% | $1194万 | 4.4% |
| 10 | PCVX Vaxcyte Inc | 200,000 | −31.0% | $1163万 | 4.3% |
| 11 | MDWD Mediwound Ltd | 749,054 | +0.0% | $1101万 | 4.1% |
| 12 | CLDX Celldex Therapeutics Inc New | 200,000 | −39.4% | $744万 | 2.8% |
| 13 | BCRX Biocryst Pharmaceuticals Inc | 721,504 | −21.8% | $722万 | 2.7% |
| 14 | PROF Profound Med Corp | 828,118 | +0.0% | $551万 | 2.0% |
| 15 | TLPH Talphera Inc | 5.2M | +54.1% | $532万 | 2.0% |
| 16 | AVIR Atea Pharmaceuticals Inc | 1.1M | −8.6% | $498万 | 1.8% |
| 17 | MYO Myomo Inc | 3.6M | −5.4% | $378万 | 1.4% |
| 18 | OVID Ovid Therapeutics Inc | 1.1M | +0.0% | $298万 | 1.1% |
| 19 | NRXS Neuraxis Inc | 508,055 | +77.6% | $297万 | 1.1% |
| 20 | ABVX Abivax Sa | 20,869 | — | $278万 | 1.0% |
| 21 | NSPR Inspiremd Inc | 3.9M | +0.0% | $273万 | 1.0% |
| 22 | RGNT Regentis Biomaterials Ltd | 701,685 | +179.0% | $248万 | 0.9% |
| 23 | PYPD Polypid Ltd | 389,455 | −34.9% | $198万 | 0.7% |
| 24 | BFRI Biofrontera Inc | 1.3M | +9.6% | $121万 | 0.4% |
| 25 | KURA Kura Oncology Inc | 100,000 | +0.0% | $110万 | 0.4% |
| 26 | SPRB Spruce Biosciences Inc | 20,000 | — | $108万 | 0.4% |
| 27 | AQST Aquestive Therapeutics Inc | 250,000 | +0.0% | $104万 | 0.4% |
| 28 | OKUR Onkure Therapeutics Inc | 150,000 | −66.2% | $68万 | 0.3% |
| 29 | PEPG Pepgen Inc | 350,000 | — | $63万 | 0.2% |